Brainstorm Cell Therapeutics Inc. (BCLI)
Market Closed
16 Jun, 20:00
OTC PINK OTC PINK Primary $
0. 85
+0.04
+4.9383%
$
8.93M Market Cap
- P/E Ratio
- Div Yield
3,547 Volume
-0.7 Eps
$ 0.81
Previous Close Want to track BCLI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
BCLI Earnings Reports FAQ
What is the earnings per share (EPS) for BCLI?
The current EPS is -0.7.
What is the company's earnings growth rate?
Brainstorm Cell Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Brainstorm Cell Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Brainstorm Cell Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for BCLI at this time, as Brainstorm Cell Therapeutics Inc has no recent EPS data to calculate it.
